1. Prevention of breast cancer by dietary polyphenols—role of cancer stem cells
   Hao-Feng Gu et al, 2019, Critical Reviews in Food Science and Nutrition CrossRef
2. Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
   null Nedeljković et al, 2019, Cells CrossRef
3. Tumorigenic and Metastatic Role of CD44−/low/CD24−/low Cells in Luminal Breast Cancer
   Rajeev Vikram et al, 2020, Cancers CrossRef
4. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis
   Lei Xing et al, 2020, Aging CrossRef
5. EXPRESSION OF CD44 AND CD24 MARKERS IN BIOPSY SAMPLES OF TRIPLE NEGATIVE BREAST CANCER PATIENTS BEFORE TREATMENT
   S. G. Smirnova et al, 2020, Sib. onkol. ž. CrossRef
6. Characteristics of Molecularly Engineered Anticancer Drug Conjugated Organic Nanomicelles for Site-Selective Cancer Cell Rupture and Growth Inhibition of Tumor Spheroids
   Nishant Kumar Jain et al, 2020, ACS Appl. Bio Mater. CrossRef
7. The Role of Serotonin in Breast Cancer Stem Cells
   William D. Gwynne et al, 2021, Molecules CrossRef
8. High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection
   Attapol Titapun et al, 2021, IJGM CrossRef
9. Novel strategies to target chemoresistant triple-negative breast cancer
   Jaganathan Venkatesh et al, 2020, Genes Cancer CrossRef
10. A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
    Mahdi Abdoli Shadbad et al, 2021, Front. Oncol. CrossRef
11. Analyzing mRNAsi-Related Genes Identifies Novel Prognostic Markers and Potential Drug Combination for Patients with Basal Breast Cancer
    Kai Huang et al, 2021, Disease Markers CrossRef
12. Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma
    Ankai Xu et al, 2021, Genes CrossRef
13. The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
    Lin He et al, 2021, Cancers CrossRef
14. Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
    Paola Ferrari et al, 2022, IJMS CrossRef
15. Breast cancer stem cells: mechanobiology reveals highly invasive cancer cell subpopulations
    Martha B. Alvarez-Elizondo et al, 2022, Cell. Mol. Life Sci. CrossRef
16. Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies
    Shinjit Mani et al, 2022, BioNanoSci. CrossRef
17. Triple-negative breast cancer drug resistance, durable efficacy, and cure: How advanced biological insights and emerging drug modalities could transform progress
    Ernestina Marianna De Francesco et al, 2022, Expert Opinion on Therapeutic Targets CrossRef
18. Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
    Françoise Derouane et al, 2022, Cancers CrossRef
19. Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer
    Lisbeth Escudero Mendez et al, 2022 CrossRef
20. Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness.
    Rinad Mahmoud et al, 2022, Cancers (Basel) CrossRef
21. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer
    Xugui Zhao et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
22. Role of Cancer Stem-like Cells in the Process of Invasion and Mesenchymal Transformation by a Reconstituted Triple-negative Breast Cancer Cell Population Resistant to p53-induced Apoptosis
    Sana Inoue et al, 2022, Acta Histochem. Cytochem. CrossRef
23. Integrating Genomic Information with Tumor-Immune Microenvironment in Triple-Negative Breast Cancer
    David Otohinoyi et al, 2022, IJERPH CrossRef
24. The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options
    Arpit Dave et al, 2023, Cell Oncol. CrossRef
25. The role of telocytes and miR-21-5p in tumorigenicity and metastasis of breast cancer stem cells
    Sena Babadag et al, 2024, Mol Biol Rep CrossRef
26. Ferroptosis as a promising targeted therapy for triple negative breast cancer
    Kasra Mokhtarpour et al, 2024, Breast Cancer Res Treat CrossRef